Cancertame: Bridging Ayurvedic Research And Modern Healthcare Through Science, Quality And Innovation

Ishan Kaushal, Director

Ishan Kaushal

Director

The growing interest in integrative healthcare has brought renewed attention to Ayurveda and its poten­tial role in supporting patients with complex medical conditions. In cancer care, however, the challenge extends beyond traditional knowledge to establishing scientific evi­dence, maintaining product consistency and ensuring patient safety. As expectations around research transparency and regulatory compliance increase, organisations operating in this specialised segment must demonstrate a disciplined ap­proach to formulation development and responsible health­care practices.

Positioned within this evolving landscape is Cancertame, an Ayurvedic formulation developed through decades of herbal research associated with Sino Vedic Research Centre. Operating under Sino Vedic Healthcare Private Limited, with products marketed through the BharatVed brand, the organisation focuses on combining traditional medicinal knowledge with structured research, manufacturing quality and digital accessibility.

The organisation's journey began in 1983, rooted in the pioneering work of the late Dr. S.P. Kaushal, an MBBS qualified physician whose concerns about chemotherapy related side effects inspired him to investigate Ayurvedic and Chinese medicinal herbs and their supportive applications in cancer care. His son, Dr. Ishan Kaushal, who became involved in the clinic's operations early on and practiced alongside him as a doctor, subsequently carried this forty year research legacy forward. Having worked closely with his father, he brought a stronger emphasis on operational efficiency, pan India telemedicine, technology adoption and wider product accessibility.

A Research Legacy Built Over Decades

Cancertame's development reflects a long term research journey that began with the investigation of approximately 400 to 500 medicinal herbs. The research involved studying individual ingredients, examining different herbal combinations and documenting patient observations over extended periods.

A central consideration throughout the process was understanding the potential interactions between herbal formulations and conventional cancer treatments. Given the complexity of oncology care, the organisation recognised the importance of evaluating ingredients carefully and ensuring all preparations remain 100 percent pure botanical extracts, completely free from heavy metals and bhasmas.

The initial formulations, including Cancertame, Oncotame and Immunotone, were developed around 1993. Subsequent years were dedicated to further clinical evaluation, documentation and regulatory processes. These core oncology formulations officially received approvals between 2010 and 2014, enabling their commercial introduction.

This research oriented approach continues to influence the organisation's development priorities. Rather than treating formulation development as a one time exercise, Cancertame emphasises ongoing assessment, documentation and refinement as integral components of its operations.

Strengthening Quality and Manufacturing Consistency

For herbal formulation manufacturers, maintaining consistency across production batches remains a significant operational challenge. Variations in natural ingredients, complex processing requirements and the need for scalable production demand carefully controlled manufacturing practices.

“We address these challenges through standardised production procedures and collaborations with pharmaceutical manufacturing partners. Our operations strictly follow ISO and GMP certified manufacturing practices, with particular attention to pure botanical ingredient specifications, zero heavy metal policies and batch level quality assessments,” shares Dr. Ishan Kaushal, Director.

A typical production batch comprises approximately 2,000 to 3,000 units, from which representative samples are selected for testing. These assessments focus on maintaining ingredient consistency and ensuring that manufacturing specifications are followed across batches. The organisation also places importance on recording patient experiences and clinical outcomes through its associated healthcare professionals, using these observations to inform further research.

For its leadership, building stakeholder confidence requires more than commercial visibility. It involves maintaining transparent processes and ensuring that product related communication remains grounded in available evidence.

Expanding Accessibility through Digital Innovation

Alongside research and manufacturing, Cancertame has focused on overcoming the commercial limitations of conventional pharmaceutical distribution. Traditional intermediaries, according to its leadership, often demanded margins ranging from 40 to 60 percent, creating considerable pricing pressures.

To reduce dependence on these channels, the organisation adopted digital marketplaces, making Cancertame available through Amazon in 2020. Its broader online distribution strategy includes platforms such as Flipkart alongside direct online video consultations, supporting patient accessibility while limiting additional distribution costs.

As the Ayurvedic healthcare sector faces increasing scrutiny, Cancertame aims to contribute through sustained research, manufacturing discipline & responsible innovation

Ishan Kaushal, Director

“Our technology adoption has since expanded beyond product availability. We have developed Cancer Talk, an AI powered healthcare information application for Android and iOS designed to respond to user queries and provide informational guidance based on medical literature, reference materials and historical case records,” speaks Dr. Ishan Kaushal.

At the time of the interview, the application was completing closed testing ahead of its public release. The initiative reflects the organisation's interest in improving access to verified healthcare information while recognising that AI generated responses require appropriate professional oversight.

Advancing Research and Responsible Integrative Care

Looking ahead, Sino Vedic Healthcare Private Limited is prioritising further evaluation of its research pipeline, including three next generation cancer formulations (Immunotone Plus, Oncotame Plus and Oncotame S) as well as expanding awareness for its ten approved chronic care formulations under the BharatVed brand, including Diabetame, Cardiovedic, Atherotame, Hepatovedic, Hormovedic, Neurovedic and Immunovedic. “Another priority involves enhancing Cancer Talk with a doctor verification feature, allowing users to request professional review of AI generated responses by qualified physicians. This is intended to strengthen information reliability and encourage informed healthcare decisions,” adds Dr. Ishan Kaushal.

Beyond product development, the organisation envisions greater collaboration between traditional and conventional medical disciplines, supported by rigorous scientific evaluation, transparent evidence and appropriate safeguards against treatment interactions.

As the Ayurvedic healthcare sector faces increasing scrutiny, Cancertame aims to contribute through sustained research, manufacturing discipline and responsible innovation. Its long term direction reflects a broader industry imperative: ensuring that traditional medicinal knowledge is examined through contemporary scientific standards, with patient safety and evidence based care remaining central to progress.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.